Inflammatory bowel disease and risk of idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis.
<h4>Introduction</h4>Inflammatory bowel disease is a relapsing chronic gastrointestinal inflammatory disease. Idiopathic pulmonary fibrosis is a rare but serious extraintestinal pulmonary manifestation of inflammatory bowel disease. However, the relationship between these two conditions...
Main Authors: | Jiali Wang, Fushun Kou, Xiao Han, Lei Shi, Rui Shi, Zhibin Wang, Tangyou Mao, Junxiang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0270297 |
Similar Items
-
Hewei Jiangni granule alleviates visceral hypersensitivity in a rat model of non-erosive reflux disease via transient receptor potential channel signaling
by: Jiali Liu, et al.
Published: (2020-04-01) -
Idiopathic pulmonary fibrosis
by: Noble Paul W, et al.
Published: (2008-03-01) -
Circulating inflammatory cytokines and risk of idiopathic pulmonary fibrosis: a Mendelian randomization study
by: Qinyao Jia, et al.
Published: (2023-10-01) -
The role of Akkermansia muciniphila in inflammatory bowel disease: Current knowledge and perspectives
by: Mengyu Zheng, et al.
Published: (2023-01-01) -
CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential
by: Shanshan Liu, et al.
Published: (2023-02-01)